author-photo

Elizabeth Chien Hern Liow

14

Papers

41

Citations

Citation Trend

Filter By

Papers (9) Sort By

Journal Conference Others

A phase I open label dose‐escalation study to evaluate the tolerability, safety and immunological efficacy of sub‐urothelial durvalumab injection in adults with muscle‐invasive or high‐risk non‐muscle‐invasive bladder cancer (SUBDUE‐1, SUB‐urothelial DUrvalumab injection‐1 study): clinical trial protocol

2021 BJUI
Show All
- Source
- Cite
- Save
Citations (0)
UNISON - nivolumab then ipilimumab + nivolumab in advanced non-clear cell renal cell carcinoma (ANZUP 1602): Part 1—Nivolumab monotherapy.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Sub-urothelial durvalumab injection-1 (SUBDUE-1): A novel approach to immunotherapy for bladder cancer.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
UNISON: Nivolumab then ipilimumab + nivolumab in advanced nonclear cell renal cell carcinoma (ANZUP 1602).

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Real-world clinical effectiveness of second-line sunitinib following immuno-oncology therapy in patients with metastatic renal cell carcinoma

2020
Show All
- Source
- Cite
- Save
Citations (0)
Adding mitomycin to Bacillus Calmette-Guérin as adjuvant intravesical therapy for high-risk, nonmuscle-invasive urothelial bladder cancer (BCGMM; ANZUP 1301).

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
First-line (1L) immuno-oncology (IO) combination therapies in metastatic renal-cell carcinoma (mRCC): Results from the international mRCC database consortium (IMDC).

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (4)
First-line (1L) immuno-oncology (IO) combination therapies in metastatic renal cell carcinoma (mRCC): Preliminary results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (4)
Accessing tissue for research: Pathology provider policies and attitudes to tumor sample use.

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)